Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Brief look at how volume relates to index chart moves, demonstrating how volume spikes can confirm or warn against breakout signals.
28,655 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Housing affordability deteriorates as starter homes in dozens of metros breach seven-figure prices. A new study shows...
Ethereum edges higher ahead of a major network upgrade, with an analyst signaling potential upside as on-chain use st...
As AI infrastructure spending stays robust, memory names SanDisk and Micron pursue starkly different paths. SanDisk l...
Myro (MYRO) faces a high-volatility path as traders eye 2025 to 2030 targets. This report lays out the price scenario...
Cava posted a record year, topping rivals with 2025 revenue of $1.169 billion and 72 new restaurants. The chain signa...
The U.S. and allies are releasing barrels from reserves to ease rising gas costs, but analysts caution the relief may...
Insider trades can hint at a company's future, but not every move is meaningful. This article shows how to filter sig...
When a company director sells millions after a sharp rally, it stirs worry. But insider activity is nuanced. This gui...
When Apple speaks at WWDC, markets listen. This article breaks down how Apple Just Delivered News about AI strategy, ...
Turn your know-how into steady income with a practical plan. This guide shows how to find your niche, price your offe...
Most taxpayers overlook deductions that can trim tax bills. This complete checklist reveals hidden write-offs, simple...